skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8850

Effect of Holostemma annularis on the progression of diabetes induced by a high fructose diet in rats and in diabetic C57BL/6J ob/ob mice

Original Research

(2409) Views  (847) Full article downloads

Authors: Sudharshan Reddy D, Muchandi IS, Srinivasa Rao A, et al

Published Date April 2010 Volume 2010:3 Pages 87 - 94
DOI: http://dx.doi.org/10.2147/DMSO.S9099

Sudharshan Reddy D1, Muchandi IS2, Srinivasa Rao A3, Pradeep HA1, Ravi Kumar K1, Srinivasa Rao M1, Mohammed Ibrahim1

1Nizam Institute of Pharmacy, Hyderabad, Andhra Pradesh, India; 2HSK College of Pharmacy, Bagalkot, Karnataka, India; 3Bhaskar College of Pharmacy, Hyderabad, Andhra Pradesh, India

Abstract: The roots of Holostemma annularis K. Schum (Asclepiadacae) are used in traditional medicine to treat diabetes. This medicinal plant, widely used in more than 34 ayurvedic preparations, was evaluated in a high fructose diet in induced insulin resistance and in C57BL/6J ob/ob diabetic mice for its antidiabetic activity. Graded doses of both chloroform and methanolic extracts of the roots of H. annularis were administered to normal and experimental diabetic rats for 21 days. Serum glucose, triglycerides, cholesterol levels and total protein in urine were analyzed. Significant results were observed in the estimated parameters. These data justify the use of the plant in the treatment of diabetes mellitus and is a potential source for the isolation of new active agents for diabetes mellitus.

Keywords: Holostemma annularis, high fructose diet, antihyperglycemic, C57BL/6J ob/ob mice






 

Other articles by Dr Mohammed Ibrahim



Readers of this article also read:

Periosteoplasty for covering gingival recessions: Clinical results
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
A molecular mechanism for diacylglycerol-mediated promotion of negative caloric balance
Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
Tackling obesity: new therapeutic agents for assisted weight loss
Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Erratum
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio